Why the study?
Does simultaneous measurement of serum T and A predict metabolic risk in women with PCOS?
Does simultaneous measurement of serum T and A predict metabolic risk in women with PCOS?
Simultaneous measurement of serum testosterone and androstenedione is a useful biomarker strategy for predicting metabolic risk in women with PCOS.
Hypothesis-generating for combined T and A measurement in PCOS metabolic risk; prospective validation needed before clinical adoption.
Simultaneous measurement of serum T and A represents a useful tool for predicting metabolic risk in PCOS women. HA levels are a sensitive indicator of PCOS-related androgen excess.
No takes yet. Share an insight, caveat, or question.
O’Reilly et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: